Hansa Biopharma AB (publ)
HNSBF News Today: Stay Updated with the Latest Hansa Biopharma AB (publ) News in Real Time
Find HNSBF news now at Meyka AI. Stay informed with the latest Hansa Biopharma AB (publ) stocks updates, including price news, market analysis, and expert insights.
IDIA.SW Idorsia Ltd (SIX) CHF3.08 pre-market 21 Mar 2026: most active, B+ outlook
Pre-market: IDIA.SW stock at CHF3.08 on 21 Mar 2026, high volume 1.98M; Meyka AI gives B+ and model shows upside
RPGLF stock 95% slide to $0.006 Endurance RP Limited (PNK) 20 Mar 2026: outlook
RPGLF stock plunged 95% to $0.006 on 20 Mar 2026. Analysis of drivers, liquidity and Meyka AI forecast for RPGLF stock
HTGMQ (HTG Molecular Diagnostics) PNK at $0.0001 19 Mar 2026: top gainer insight
HTGMQ stock jumps to $0.0001 on PNK 19 Mar 2026; Meyka AI grade, forecast and targets in USD
4588.T Oncolys (JPX) down 20.65% intraday 18 Mar 2026: model target and risks
Intraday: 4588.T stock falls 20.65% on JPX 18 Mar 2026. We analyse drivers, ratios, Meyka forecast and price scenarios
XVIPY (Xvivo Perfusion AB PNK) 17 Mar 2026: Oversold bounce at $6.54
XVIPY stock at **$6.54** on 17 Mar 2026. Short-term oversold bounce setup with Meyka AI forecast of **$9.58**
Leerink Maintains Outperform on ELDN (Eledon Pharmaceuticals) March 16, 2026
Leerink maintains Outperform on ELDN. Read analyst view, implications, and Meyka AI grade for ELDN analyst rating
H.C. Wainwright Maintains Buy on Savara Inc. (SVRA) March 2026
H.C. Wainwright maintains Buy on Savara Inc.; SVRA analyst rating held ahead of August PDUFA
Oncolys (4588.T) -16.48% to JPY 2702 on 13 Mar 2026 Mkt closed: watch catalysts
4588.T stock fell 16.48% to JPY 2,702 on 13 Mar 2026. Volume 2,399,900. Short-term support and analyst view for JPX trading
XVIPY $6.54 Xvivo Perfusion AB (PNK) 13 Mar 2026: oversold bounce, watch $8.00 target
XVIPY stock at $6.54 shows an oversold bounce on 13 Mar 2026; Meyka AI forecast 1-year $9.58, implied upside 46.48%